Literature DB >> 26272189

Anticancer drugs: A one-two punch for KRAS-driven cancer.

Megan Cully.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26272189     DOI: 10.1038/nrd4710

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.

Authors:  Felix Dietlein; Bastian Kalb; Mladen Jokic; Elisa M Noll; Alexander Strong; Lars Tharun; Luka Ozretić; Helen Künstlinger; Kato Kambartel; Winfried J Randerath; Christian Jüngst; Anna Schmitt; Alessandro Torgovnick; André Richters; Daniel Rauh; Florian Siedek; Thorsten Persigehl; Cornelia Mauch; Jirina Bartkova; Allan Bradley; Martin R Sprick; Andreas Trumpp; Roland Rad; Dieter Saur; Jiri Bartek; Jürgen Wolf; Reinhard Büttner; Roman K Thomas; H Christian Reinhardt
Journal:  Cell       Date:  2015-07-02       Impact factor: 41.582

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.